LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.31623
 34.30 27.76 1280 2449 0.5225 0.8089
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 34.30 27.76 1386 2449 0.5658 0.8313
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 34.30 27.76 1441 2449 0.5882 0.8424
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 34.30 27.76 1689 2449 0.6895 0.8882
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 34.30 27.76 1742 2449 0.7111 0.8972
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 36.01 27.76 1303 2662 0.4893 0.7943
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 36.01 27.76 1337 2662 0.5021 0.8013
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 36.01 27.76 1433 2662 0.5381 0.8204
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 36.01 27.76 1496 2662 0.5618 0.8323
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 36.01 27.76 1790 2662 0.6722 0.8829
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 36.01 27.76 1853 2662 0.6959 0.8928
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 37.71 27.76 1367 2877 0.4750 0.7896
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 37.71 27.76 1394 2877 0.4844 0.7948
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 37.71 27.76 1495 2877 0.5195 0.8137
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 37.71 27.76 1555 2877 0.5404 0.8244
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 37.71 27.76 1877 2877 0.6523 0.8764
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 37.71 27.76 1925 2877 0.6690 0.8835
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 39.41 27.76 1389 3105 0.4473 0.7770
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 39.41 27.76 1422 3105 0.4579 0.7831
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 39.41 27.76 1577 3105 0.5078 0.8104
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 39.41 27.76 1622 3105 0.5223 0.8179
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 39.41 27.76 1929 3105 0.6211 0.8648
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 39.41 27.76 1970 3105 0.6343 0.8706
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 41.11 27.76 1454 3331 0.4364 0.7738
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 41.11 27.76 1489 3331 0.4470 0.7799
MN20160318_Q01
G09